Sweden
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotic, BMJ Mental Health, cardiovascular disease, cardiovascular events, cohort study, Denmark, Editor Eimear Foley, electronic health records, external validation, health inequalities, lasso regression, logistic regression, machine learning, mixed methods, mortality gap, physical health, physical health inequalities, prediction, psychosis, registry data, risk factors, risk prediction, schizophrenia, Sweden, topical, xgboostPredicting cardiovascular disease in schizophrenia: does machine learning actually help?
On average, people with schizophrenia spectrum disorders die 15 to 20 years…
-
antipsychotic, BMJ Mental Health, cardiovascular disease, cardiovascular events, cohort study, Denmark, Editor Eimear Foley, electronic health records, external validation, health inequalities, lasso regression, logistic regression, machine learning, mixed methods, mortality gap, physical health, physical health inequalities, prediction, psychosis, registry data, risk factors, risk prediction, schizophrenia, Sweden, topical, xgboostPredicting cardiovascular disease in schizophrenia: does machine learning actually help?
On average, people with schizophrenia spectrum disorders die 15 to 20 years…
